Menu

Baudax Bio, Inc. BXRX

Full chart Compare
Set alert

Price alert · BXRX

All alert types
0.02 USD 0.00 (+0.00%)

Feb 29, 2024, 3:53 PM EST

0.02 Day range 0.022025
0.0137 52-week range 3.47

Revenue & Expenses

Net Loss → Expenses: $58.80MExpenses → Gross Loss: $5.74MExpenses → Selling, General & Admin: $24.12MExpenses → Research & Development: $5.88MExpenses → Interest Expense: $21.07MExpenses → Other Expenses: $1.98MRevenue → Cost of Revenue: $1.27MNet Loss$58.80MCost of Revenue$7.01MExpenses$58.80MGross Loss$5.74MSelling, General & Admin$24.12MResearch & Development$5.88MInterest Expense$21.07MOther Expenses$1.98MRevenue$1.27M

Latest period ending Dec 31, 2022 · select a line to chart its full history

BXRX annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
1.27M1.08M493.00K00
-5.74M-1.36M-1.24M00
-59.58M-52.38M-55.81M-47.07M-65.04M
-58.80M-19.77M-76.10M-32.56M-73.67M
-177.30-361.16-5,714.80-4,872.01-11,032.01
BXRX annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
5.26M15.89M30.34M17.74M0
10.03M53.28M68.73M54.21M35.02M
34.27M40.05M83.53M70.93M103.37M
7.93M8.53M9.15M773.00K0
-24.24M13.23M-14.80M-16.72M-68.35M
BXRX annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-27.79M-49.27M-44.06M-50.04M-59.75M
-20.00K-194.00K-639.00K-1.48M-3.45M
17.18M35.01M57.30M69.27M63.20M
-20.00K-203.00K-639.00K-1.48M-3.45M
-10.63M-14.45M12.60M17.74M0